1,278
Views
7
CrossRef citations to date
0
Altmetric
Review

The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach

, , , , ORCID Icon, & show all
Pages 623-632 | Published online: 14 Jun 2021

References

  • Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534. doi:10.1038/jid.2013.446
  • Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol. 2017;153(5):406–412. doi:10.1001/jamadermatol.2016.5538
  • Dreno B, Poli F. Epidemiology of acne. Dermatology. 2003;206(1):7–10. doi:10.1159/000067817
  • Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl 1):3–12. doi:10.1111/bjd.13462
  • Kowalska-Olędzka E, Czarnecka M, Baran A. Epidemiology of atopic dermatitis in Europe. J Drug Assess. 2019;8(1):126–128. doi:10.1080/21556660.2019.1619570
  • Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16. doi:10.1159/000370220
  • Hendricks AJ, Eichenfield LF, Shi VY. The impact of airborne pollution on atopic dermatitis: a literature review. Br J Dermatol. 2020;183(1):16–23. doi:10.1111/bjd.18781
  • Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937
  • Sibaud V. Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy. Am J Clin Dermatol. 2018;19(3):345–361. doi:10.1007/s40257-017-0336-3
  • Lacouture M, Sibaud V. Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails. Am J Clin Dermatol. 2018;19(Suppl 1):31–39. doi:10.1007/s40257-018-0384-3
  • Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol. 2019;81(2):558–567. doi:10.1016/j.jaad.2019.02.047
  • Jourdan M, Madfes DC, Lima E, Tian Y, Seité S. Skin care management for medical and aesthetic procedures to prevent scarring. Clin Cosmet Investig Dermatol. 2019;12:799–804. doi:10.2147/CCID.S218134
  • Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14(5):R188. doi:10.1186/cc9300
  • Jørgensen SF, Nygaard R, Posnett J. Meeting the challenges of wound care in Danish home care. J Wound Care. 2013;22(10):540–545. doi:10.12968/jowc.2013.22.10.540
  • Davern J, O’Donnell AT. Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers. PLoS One. 2018;13(9):e0205009. doi:10.1371/journal.pone.0205009
  • Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637. doi:10.1016/j.jpsychores.2005.10.020
  • Nagpal N, Gordon-Elliott J, Lipner S. Comparison of quality of life and illness perception among patients with acne, eczema, and psoriasis. Dermatol Online J. 2019;25:5.
  • Basra MK, Sue-Ho R, Finlay AY. The family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156(3):528–538. doi:10.1111/j.1365-2133.2006.07617.x
  • Finlay AY, Salek MS, Abeni D, et al. Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV task force on quality of life. J Eur Acad Dermatol Venereol. 2017;31(3):424–431. doi:10.1111/jdv.13985
  • Finlay AY. Quimp: a word meaning “quality of life impairment”. Acta Derm Venereol. 2017;97(4):546–547. doi:10.2340/00015555-2650
  • Misery L, Taïeb C, Schollhammer M, et al. Psychological consequences of the most common dermatoses: data from the objectifs Peau study. Acta Derm Venereol. 2020;100(13):adv00175. doi:10.2340/00015555-3531
  • Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–676. doi:10.1046/j.1365-2133.1999.02768.x
  • Cresce ND, Davis SA, Huang WW, Feldman SR. The quality of life impact of acne and rosacea compared to other major medical conditions. J Drugs Dermatol. 2014;13(6):692–697.
  • Dreno B, Bordet C, Seite S, Taieb C. Acne relapses: impact on quality of life and productivity. J Eur Acad Dermatol Venereol. 2019;33(5):937–943. doi:10.1111/jdv.15419
  • Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–347. doi:10.1016/j.anai.2018.07.006
  • Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema association. J Invest Dermatol. 2017;137(1):26–30. doi:10.1016/j.jid.2016.07.012
  • Barrett A, Hahn-Pedersen J, Kragh N, Evans E, Gnanasakthy A. Patient-reported outcome measures in atopic dermatitis and chronic hand Eczema in adults. Patient. 2019;12(5):445–459. doi:10.1007/s40271-019-00373-y
  • Thomas DR. Psychosocial effects of acne. J Cutan Med Surg. 2004;8(Suppl 4):3–5. doi:10.1007/s10227-004-0752-x
  • Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707–713. doi:10.1111/1523-1747.ep12365600
  • Hahm BJ, Min SU, Yoon MY, et al. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. J Dermatol. 2009;36(5):255–261. doi:10.1111/j.1346-8138.2009.00635.x
  • Cengiz GF, Gürel G. Difficulties in emotion regulation and quality of life in patients with acne. Qual Life Res. 2020;29(2):431–438. doi:10.1007/s11136-019-02318-2
  • Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131(2):363–370. doi:10.1038/jid.2010.264
  • Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984–991. doi:10.1038/jid.2014.530
  • Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18(4):435–439. doi:10.1111/j.1468-3083.2004.00946.x
  • Erdoğan Y, Erturan İ, Aktepe E, Akyıldız A. Comparison of quality of life, depression, anxiety, suicide, social anxiety and obsessive-compulsive symptoms between adolescents with acne receiving isotretinoin and antibiotics: a prospective, non-randomised, open-label study. Paediatr Drugs. 2019;21(3):195–202. doi:10.1007/s40272-019-00340-y
  • McLean L, Chen R, Kwiet J, Streimer J, Vandervord J, Kornhaber R. A clinical update on posttraumatic stress disorder in burn injury survivors. Australas Psychiatry. 2017;25(4):348–350. doi:10.1177/1039856217700285
  • Taal LA, Faber AW. Posttraumatic stress and maladjustment among adult burn survivors 1–2 years postburn. Burns. 1998;24(4):285–292. doi:10.1016/S0305-4179(98)00030-8
  • Gojowy D, Kauke M, Ohmann T, Homann HH, Mannil L. Early and late-recorded predictors of health-related quality of life of burn patients on long-term follow-up. Burns. 2019;45(6):1300–1310. doi:10.1016/j.burns.2019.03.016
  • Gieler U, Gieler T, Kupfer JP. Acne and quality of life - impact and management. J Eur Acad Dermatol Venereol. 2015;29(Suppl 4):12–14. doi:10.1111/jdv.13191
  • Kant SB, Colla C, Van den Kerckhove E, Van der Hulst R, Piatkowski de Grzymala A. Satisfaction with facial appearance and quality of life after treatment of face scars with a transparent facial pressure mask. Facial Plast Surg. 2018;34(4):394–399. doi:10.1055/s-0038-1648249
  • Brewin MP, Homer SJ. The lived experience and quality of life with burn scarring-the results from a large-scale online survey. Burns. 2018;44(7):1801–1810. doi:10.1016/j.burns.2018.04.007
  • Limongelli P, Casalino G, Tolone S, et al. Quality of life and scar evolution after negative pressure or conventional therapy for wound dehiscence following post-bariatric abdominoplasty. Int Wound J. 2017;14(6):960–966. doi:10.1111/iwj.12739
  • Young VL, Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg. 2009;124(1):256–265. doi:10.1097/PRS.0b013e3181a80747
  • Schnur JB, Ouellette SC, Bovbjerg DH, Montgomery GH. Breast cancer patients’ experience of external-beam radiotherapy. Qual Health Res. 2009;19(5):668–676. doi:10.1177/1049732309334097
  • Schnur JB, Ouellette SC, Dilorenzo TA, Green S, Montgomery GH. A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients. Psychooncology. 2011;20(3):260–268. doi:10.1002/pon.1734
  • Beamer LC, Grant M. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: a pilot study. Eur J Oncol Nurs. 2018;33:22–27. doi:10.1016/j.ejon.2018.01.008
  • Gandhi M, Oishi K, Zubal B, Lacouture ME. Unanticipated toxicities from anticancer therapies: survivors’ perspectives. Support Care Cancer. 2010;18(11):1461–1468. doi:10.1007/s00520-009-0769-1
  • Hackbarth M, Haas N, Fotopoulou C, Lichtenegger W, Sehouli J. Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study. Support Care Cancer. 2008;16(3):267–273. doi:10.1007/s00520-007-0318-8
  • Ra HS, Shin SJ, Kim JH, Lim H, Cho BC, Roh MR. The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients. J Eur Acad Dermatol Venereol. 2013;27(1):e53–59. doi:10.1111/j.1468-3083.2012.04466.x
  • Sibaud V, Lebœuf NR, Roche H, et al. Dermatological adverse events with taxane chemotherapy. Eur J Dermatol. 2016;26(5):427–443. doi:10.1684/ejd.2016.2833
  • Halvorsen JA, Lien L, Dalgard F, Bjertness E, Stern RS. Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. J Invest Dermatol. 2014;134(7):1847–1854. doi:10.1038/jid.2014.70
  • Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115–s123.
  • Silverberg NB. A practical overview of pediatric atopic dermatitis, part 2: triggers and grading. Cutis. 2016;97(5):326–329.
  • Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018;26(6):484–497. doi:10.1016/j.tim.2017.11.008
  • Diseases NIoAaI. Eczema (atopic dermatitis) causes & strategies for prevention. 2020 [ Updated June 30, 2016]. Available from: https://www.niaid.nih.gov/diseases-conditions/eczema-causes-prevention-strategies. Accessed November, 2020.
  • Wei W, Ghorayeb E, Andria M, et al. A real-world study evaluating adeQUacy of existing systemic treatments for patients with moderate-to-severe atopic dermatitis (QUEST-AD): baseline treatment patterns and unmet needs assessment. Ann Allergy Asthma Immunol. 2019;123(4):381–388.e382. doi:10.1016/j.anai.2019.07.008
  • Simons M, Kimble R, McPhail S, Tyack Z. The Brisbane Burn Scar impact profile (child and young person version) for measuring health-related quality of life in children with burn scars: a longitudinal cohort study of reliability, validity and responsiveness. Burns. 2019;45(7):1537–1552. doi:10.1016/j.burns.2019.07.012
  • Rossi AM, Blank NR, Nehal K, Dusza S, Lee EH. Effect of laser therapy on quality of life in patients with radiation-induced breast telangiectasias. Lasers Surg Med. 2018;50(4):284–290. doi:10.1002/lsm.22780
  • Lee J, Lim J, Park JS, et al. The impact of skin problems on the quality of life in patients treated with anticancer agents: a cross-sectional study. Cancer Res Treat. 2018;50(4):1186–1193. doi:10.4143/crt.2017.435
  • Rea CJ, Tran KD, Jorina M, Wenren LM, Hawryluk EB, Toomey SL. Associations of eczema severity and parent knowledge with child quality of life in a pediatric primary care population. Clin Pediatr. 2018;57(13):1506–1514. doi:10.1177/0009922818787295
  • Chang YS, Chiang BL. Mechanism of sleep disturbance in children with atopic dermatitis and the role of the circadian rhythm and melatonin. Int J Mol Sci. 2016;17(4):462. doi:10.3390/ijms17040462
  • Camfferman D, Kennedy JD, Gold M, Martin AJ, Lushington K. Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev. 2010;14(6):359–369. doi:10.1016/j.smrv.2010.01.004
  • Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol. 2006;154(3):514–518. doi:10.1111/j.1365-2133.2005.07082.x
  • Ricci G, Bendandi B, Bellini F, Patrizi A, Masi M. Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol. 2007;18(3):245–249. doi:10.1111/j.1399-3038.2006.00502.x
  • Ben-Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol. 2002;16(5):455–462. doi:10.1046/j.1468-3083.2002.00495.x
  • Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226–232. doi:10.1016/j.jaci.2006.02.031
  • Haufe E, Abraham S, Heratizadeh A, et al. [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema: results from the German atopic eczema registry TREATgermany]. Hautarzt. 2018;69(10):815–824. doi:10.1007/s00105-018-4261-z
  • Haruna F, Lipsett A, Marignol L. Topical management of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis.. Anticancer Res. 2017;37(10):5343–5353. doi:10.21873/anticanres.11960
  • Dalenc F, Ribet V, Rossi AB, et al. Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: a randomised, controlled study. Eur J Cancer Care. 2018;27(1):e12735. doi:10.1111/ecc.12735
  • Chernyshov PV, Tomas-Aragones L, Manolache L, et al. Which acne treatment has the best influence on health-related quality of life? Literature review by the European academy of dermatology and venereology task force on quality of life and patient oriented outcomes. J Eur Acad Dermatol Venereol. 2018;32(9):1410–1419. doi:10.1111/jdv.15048
  • Drost BH, van de Langenberg R, Manusama OR, et al. Dermatography (Medical Tattooing) for Scars and Skin Grafts in Head and Neck Patients to Improve Appearance and Quality of Life. JAMA Facial Plast Surg. 2017;19(1):16–22. doi:10.1001/jamafacial.2016.1084
  • Serra-Añó P, Inglés M, Bou-Catalá C, Iraola-Lliso A, Espí-López GV. Effectiveness of myofascial release after breast cancer surgery in women undergoing conservative surgery and radiotherapy: a randomized controlled trial. Support Care Cancer. 2019;27(7):2633–2641. doi:10.1007/s00520-018-4544-z
  • Urakawa R, Tarutani M, Kubota K, Uejima E. Hand foot syndrome has the strongest impact on QOL in skin toxicities of chemotherapy. J Cancer. 2019;10(20):4846–4851. doi:10.7150/jca.31059
  • Carvalho D, Aguiar P, Mendes-Bastos P, Palma-Carlos A, Freitas J, Ferrinho P. Quality of life and characterization of patients with atopic dermatitis in Portugal - QUADEP study. J Investig Allergol Clin Immunol. 2019. doi:10.18176/jiaci.0443
  • David SE, Ahmed Z, Salek MS, Finlay AY. Does enough quality of life-related discussion occur during dermatology outpatient consultations? Br J Dermatol. 2005;153(5):997–1000. doi:10.1111/j.1365-2133.2005.06876.x
  • Carr T, Harris D, James C. The Derriford Appearance Scale (DAS-59): a new scale to measure individual responses to living with problems of appearance. Br J Health Psychol. 2000;5(2):201–215. doi:10.1348/135910700168865
  • Den Ouden H, Vos RC, Rutten G. Effectiveness of shared goal setting and decision making to achieve treatment targets in type 2 diabetes patients: a cluster-randomized trial (OPTIMAL). Health Expect. 2017;20(5):1172–1180. doi:10.1111/hex.12563
  • Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012;344:e256. doi:10.1136/bmj.e256
  • Brown A. Implications of patient shared decision-making on wound care. Br J Community Nurs. 2013;18(Sup6):SS26. doi:10.12968/bjcn.2013.18.Sup6.S26
  • LeBovidge J, Borok J, Udkoff J, Yosipovitch G, Eichenfield LF. Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care. Semin Cutan Med Surg. 2017;36(3):131–136. doi:10.12788/j.sder.2017.029
  • Kwong BY. Outcomes of embedding dermatologic care within oncology practices for patients with cancer. JAMA Dermatol. 2020;156(10):1051. doi:10.1001/jamadermatol.2020.1794
  • Chen ST, Molina GE, Lo JA, et al. Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: a retrospective cohort study. J Am Acad Dermatol. 2020;82(4):994–996. doi:10.1016/j.jaad.2019.09.026
  • Naidoo J, Zhang J, Lipson EJ, et al. A multidisciplinary toxicity team for cancer immunotherapy-related adverse events. J Natl Compr Canc Netw. 2019;17(6):712–720. doi:10.6004/jnccn.2018.7268
  • Beamer LC, Grant GM. Skin-related quality of life among midwestern US community-based women with breast cancer experiencing radiodermatitis. Asia Pac J Oncol Nurs. 2019;6(1):50–56. doi:10.4103/apjon.apjon_40_18
  • Marinello E, Linder D, Spoto A, et al. Assessing the impact of atopic dermatitis on the patients’ parents with the visual instrument ‘Caregiver-PRISM’. Dermatology. 2016;232(4):490–495. doi:10.1159/000448030
  • Fuzissaki MA, Paiva CE, Oliveira MA, Lajolo Canto PP, Paiva Maia YC. The impact of radiodermatitis on breast cancer patients’ quality of life during radiotherapy: a prospective cohort study. J Pain Symptom Manage. 2019;58(1):92–99.e91. doi:10.1016/j.jpainsymman.2019.03.017
  • Chernyshov PV, Tomas-Aragones L, Manolache L, et al. Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) Task Force on quality of life. J Eur Acad Dermatol Venereol. 2017;31(4):576–593. doi:10.1111/jdv.14058
  • Vakharia PP, Cella D, Silverberg JI. Patient-reported outcomes and quality of life measures in atopic dermatitis. Clin Dermatol. 2018;36(5):616–630. doi:10.1016/j.clindermatol.2018.05.011
  • Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 2019;6:12. doi:10.3390/children6120133
  • Heinl D, Prinsen CAC, Sach T, et al. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review. Br J Dermatol. 2017;176(4):878–889. doi:10.1111/bjd.14966
  • Pattinson RL, Trialonis-Suthakharan N, Gupta SG, et al. Patient-reported measures in dermatology: a systematic review. Eur Acad Dermatol Venereol. 2019.
  • Global Skin. About GRIDD. Available from: https://globalskin.org/research/gridd-about. Accessed December, 2020.